Viewing Study NCT01144260


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-06 @ 5:58 PM
Study NCT ID: NCT01144260
Status: COMPLETED
Last Update Posted: 2013-05-15
First Post: 2010-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Sponsor: CytRx
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None leukemia View
None chronic lymphocytic leukemia View